A landmark mammography study has found that women who receive annual breast cancer screenings will have a lower mortality rate and will benefit more from therapy upon diagnosis of breast cancer. The lead investigator on this study was László Tabár, MD. He and his ...

In the year since announcing an ambitious, $5 billion fundraising campaign, UC San Francisco has seen record-breaking generosity from its supporters, inspired by faculty-led ideas to tackle some of the toughest problems in health and science. See More of UCSF’s 2018 Year in Review » ...

Black men in the United States are known to suffer disproportionately from prostate cancer. Now, a new study investigating prostate cancer deaths by race has found that African American men have twice the chance of dying from low-risk prostate cancer than men of other racial ...

Precision medicine, immunotherapy, and population health led the news at the UCSF Helen Diller Family Comprehensive Cancer Center in 2018.  Whether through expediting drug discovery, tailoring genomic sequencing, or expanding palliative care, our UCSF cancer community remained committed to improving outcomes for every cancer ...

UC San Francisco scientists have figured out why some lung cancers become drug-resistant after initially responding to targeted therapies. In the process, they devised a new two-pronged approach that yields an effective treatment for these cancers in the laboratory and holds tremendous promise for the ...

For nearly four decades, the main option for breast reconstruction for women who had to undergo a mastectomy was to place implants under the main chest muscle – a procedure that often results in chronic pain and muscle weakness in the chest and arms. Hani ...